Concepedia

1186 SAFETY AND ANTIVIRAL ACTIVITY OF ABT-267, A NOVEL NS5A INHIBITOR, DURING 3-DAY MONOTHERAPY: FIRST STUDY IN HCV GENOTYPE-1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS

Eric Lawitz, T. Marbury, Andrew Campbell, Emily O. Dumas, Mudra Kapoor, Preethi Krishnan, Carolyn M. Setze, Wenhui Xie, Thomas Podsadecki, Barry Bernstein,

Journal of Hepatology · 2012 · 24 citations · 0 references

DOI

Concepts